Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels
Mirjana Šumarac-Dumanović(University of Belgrade), Vladimir Trajković(University of Belgrade), Dragan Micić, Aleksandar Pantovic(University of Belgrade), Darko Stevanović(Erasmus MC), Goran Cvijović(University of Belgrade), Danka Jeremić(Center for Health, Exercise and Sport Sciences), Danica Stamenkovic-Pejkovic(University of Belgrade), Kristina Janjetović(University of Belgrade)
Cited by 51
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|857
In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes
|Biomaterials|2010|560
Biomedical potential of the reactive oxygen species generation and quenching by fullerenes (C60)
|Biomaterials|2008|463
Graphene quantum dots as autophagy-inducing photodynamic agents
|Biomaterials|2012|442
Photodynamic antibacterial effect of graphene quantum dots
|Biomaterials|2014|414